Search
-
Public Opinion on the COVID-19 pandemic
In an uncertain world, data matters. Ipsos experts share the latest research and analysis related to the coronavirus pandemic.
-
THE SHOPPING FORMATS SETTING RETAIL TRENDS
This is the time of the omnichannel shopper, and online and offline channels are increasingly merging into a single seamless phygital environment, so new technologies play an important role. What are the main features of a new shopper and ways to develop commerce?
-
Flair Russia 2022 - In the Flow of Change
Fascinating insights in the latest in-depth analysis of Russian society, markets and people by our local Ipsos team.
-
Flair Russia 2022 - In the Flow of Change
Fascinating insights in the latest in-depth analysis of Russian society, markets and people by our local Ipsos team.
-
Putting in the Effort: Why treating customers fairly is key to business success
Measuring customer effort in isolation is not enough. Organisations need to measure the Customer: Company Effort Ratio (C:CER) which takes both perceived customer and company effort into account.
-
Ipsos Update - January 2022
We start the year with a look at the global public’s predictions for 2022 and the latest research on the key issues ahead, including inflation, living with Covid-19, and climate change.
-
Glocal
The point at which local culture is influenced and reformed by external global trends. Glocal culture celebrates the external influences of globalisation through a cultural norming worldwide. The concept of glocal plays a role in the way we interpret human and social truths.
-
A Year in Review - 2021
What did we learn about public attitudes and behaviours? What did our research tell us about the events of the year? And how did our outlook shift?
-
How has the Covid crisis impacted the image of pharmaceutical companies in France?
2021 put the spotlight firmly on pharmaceutical companies, whose image has been enhanced by the leading role they have played in combating the pandemic. Confidence indicators in the industry itself, as well as in pharmaceutical products and vaccines in general, are on the rise, but cannot conceal structural image issues for the sector as a whole, as is the case with combating shortages or the pursuit of the public interest.